A Novel Somatic Deletion Mutation of ATP2B3 in Aldosterone-Producing Adenoma

[1]  R. Kuick,et al.  Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands , 2015, Proceedings of the National Academy of Sciences.

[2]  T. Yoshimoto,et al.  Integration of transcriptome and methylome analysis of aldosterone-producing adenomas. , 2015, European journal of endocrinology.

[3]  Ji-Guang Wang,et al.  Clinical Characteristics of Somatic Mutations in Chinese Patients With Aldosterone-Producing Adenoma , 2015, Hypertension.

[4]  P. Mulatero,et al.  Understanding primary aldosteronism: impact of next generation sequencing and expression profiling , 2015, Molecular and Cellular Endocrinology.

[5]  T. Strom,et al.  Genetic Spectrum and Clinical Correlates of Somatic Mutations in Aldosterone-Producing Adenoma , 2014, Hypertension.

[6]  H. Sasano,et al.  Adrenal CYP11B1/2 expression in primary aldosteronism: Immunohistochemical analysis using novel monoclonal antibodies , 2014, Molecular and Cellular Endocrinology.

[7]  H. Sasano,et al.  Development of monoclonal antibodies against human CYP11B1 and CYP11B2 , 2014, Molecular and Cellular Endocrinology.

[8]  Yonghong Wang,et al.  Integrated analysis of genome-wide methylation and gene expression shows epigenetic regulation of CYP11B2 in aldosteronomas. , 2014, The Journal of clinical endocrinology and metabolism.

[9]  G. Clayman,et al.  Detection of thyroid cancer stem cells in papillary thyroid carcinoma. , 2014, The Journal of clinical endocrinology and metabolism.

[10]  F. Beuschlein,et al.  Somatic ATP1A1, ATP2B3, and KCNJ5 Mutations in Aldosterone-Producing Adenomas , 2014, Hypertension.

[11]  James Hadfield,et al.  Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension , 2013, Nature Genetics.

[12]  Annabelle L. Fonseca,et al.  Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism , 2013, Nature Genetics.

[13]  Yen-Hung Lin,et al.  Diagnosis and management of primary aldosteronism: An updated review , 2013, Annals of medicine.

[14]  T. Wieland,et al.  Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension , 2013, Nature Genetics.

[15]  X. Jeunemaître,et al.  Integrating Genetics and Genomics in Primary Aldosteronism , 2012, Hypertension.

[16]  H. Wallaschofski,et al.  Prevalence of Primary Aldosteronism in Patient’s Cohorts and in Population-based Studies – A Review of the Current Literature , 2011, Hormone and Metabolic Research.

[17]  S. Mane,et al.  K+ Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension , 2011, Science.

[18]  E. Carafoli,et al.  The plasma membrane Ca2+ ATPase of animal cells: structure, function and regulation. , 2008, Archives of biochemistry and biophysics.

[19]  P. Milliez,et al.  Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. , 2005, Journal of the American College of Cardiology.

[20]  G. Chatellier,et al.  Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  T. Kawamoto,et al.  Role of steroid 11 beta-hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[22]  西本 紘嗣郎.  Adrenocortical zonation in humans under normal and pathological conditions , 2011 .